Rigel Pharmaceuticals

(NASDAQ) RIGL

Current Price$26.74

Market Cap$519.10M

Since IPO (2000)-96%

5 Year-21%

1 Year+46%

1 Month-3%

Rigel Pharmaceuticals Financials at a Glance

Market Cap

$519.10M

Revenue (TTM)

$299.77M

Net Income (TTM)

$364.23M

EPS (TTM)

$18.91

P/E Ratio

1.49

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$26.74

Volume

38,618

Open

$28.53

Price

$26.74

Volume

38,618

Open

$28.53

Previous Close

$26.74

Daily Range

$25.80 - $29.49

52-Week Range

$16.88 - $52.24

Dividend

$0.00

Beta (Volatility)

1.36 (Average)

Price

$26.74

Volume

38,618

Open

$28.53

Previous Close

$26.74

Daily Range

$25.80 - $29.49

52-Week Range

$16.88 - $52.24

RIGL News

So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature

Maxx ChatskoApr 1, 2020

Page 1

RIGL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rigel Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

174

CEO

Raul R. Rodriguez, MBA

Website

www.rigel.com

Headquarters

South San Francisco, CA 94080, US

RIGL Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

42%

Net Income Margin

Return on Equity

186%

Return on Capital

30%

Return on Assets

72%

Earnings Yield

67.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$519.10M

Shares Outstanding

18.48M

Volume

38.62K

Avg. Volume

349.98K

Financials (TTM)

Gross Profit

$274.66M

Operating Income

$125.47M

EBITDA

$127.88M

Operating Cash Flow

$75.66M

Capital Expenditure

$0.00

Free Cash Flow

$75.66M

Cash & ST Invst.

$154.96M

Total Debt

$53.30M

Rigel Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$58.82M

+10.3%

Gross Profit

$54.21M

+10.8%

Gross Margin

92.17%

N/A

Market Cap

$519.10M

N/A

Market Cap/Employee

$3.20M

N/A

Employees

162

N/A

Net Income

$8.65M

-24.4%

EBITDA

$11.88M

-14.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$100.96M

+529.7%

Accounts Receivable

$49.95M

+20.2%

Inventory

$11.65M

+150.1%

Long Term Debt

$15.22M

-66.8%

Short Term Debt

$30.50M

+99.7%

Return on Assets

72.18%

N/A

Return on Invested Capital

30.01%

N/A

Free Cash Flow

$2.73M

+405.2%

Operating Cash Flow

$2.73M

+405.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FDMT4D Molecular Therapeutics, Inc.

FDMT4D Molecular Therapeutics, Inc.$10.42+7.31%

PRTAProthena Corporation plc

PRTAProthena Corporation plc$11.18-0.09%

AKBAAkebia Therapeutics, Inc.

AKBAAkebia Therapeutics, Inc.$1.48+2.07%

BCYCBicycle Therapeutics plc

BCYCBicycle Therapeutics plc$5.15+5.10%

GOSSGossamer Bio, Inc.

GOSSGossamer Bio, Inc.$0.35+4.23%

VTYXVentyx Biosciences, Inc.

VTYXVentyx Biosciences, Inc.$14.00+0.00%

OMEROmeros Corporation

OMEROmeros Corporation$14.83+0.41%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.19-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14-0.12%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.58+0.05%

SNAPSnap

SNAPSnap$6.11+0.33%

CTRACoterra Energy

CTRACoterra Energy$32.56-0.09%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.57+0.06%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.59-0.06%

Questions About RIGL

What is the current price of Rigel Pharmaceuticals?

Rigel Pharmaceuticals is trading at $26.74 per share.

What is the 52-week range for Rigel Pharmaceuticals?

Over the past 52 weeks, Rigel Pharmaceuticals has traded between $16.88 and $52.24.

How much debt does Rigel Pharmaceuticals have?

As of the most recent reporting period, Rigel Pharmaceuticals reported total debt of $45.72M.

How much cash does Rigel Pharmaceuticals have on hand?

Rigel Pharmaceuticals reported $24.41M in cash and cash equivalents in its most recent financial results.

What is Rigel Pharmaceuticals’s dividend yield?

Rigel Pharmaceuticals does not currently have a dividend yield.

Rigel Pharmaceuticals

Rigel Pharmaceuticals Financials at a Glance

RIGL News

Rigel (RIGL) Q2 Revenue Jumps 176%

Why Did the FDA Reject Rigel's EUA Application for Its COVID-19 Therapy?

3 Biotech Stocks That Could Rocket Higher

Why Rigel Pharmaceuticals Stock Jumped Today

3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring

Why Rigel Pharmaceuticals Stock Is Jumping Today

Why Rigel Pharmaceuticals Stock Skyrocketed 91% Today

So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature

RIGL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rigel Pharmaceuticals

RIGL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rigel Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RIGL

What is the current price of Rigel Pharmaceuticals?

What is the 52-week range for Rigel Pharmaceuticals?

How much debt does Rigel Pharmaceuticals have?

How much cash does Rigel Pharmaceuticals have on hand?

What is Rigel Pharmaceuticals’s dividend yield?

Premium Investing Services